Our Founders

Move at the Speed of Experience™

Christina Ansted Headshot

Christina J. Ansted, MPH, CCMEP

Co-Founder and CEO

Christina is a multifaceted biotech executive with expertise in global commercialization, medical communications and rare disease. Adept at building high-performance teams that drive value across an organization, Christina is deeply inspired to create a legacy of innovation by changing the approach to commercialization, improving rates of success and impacting the lives of patients worldwide.

Michael Janes

Michael C. Janes

Co-Founder and CRO
Head, Private Market Practice

Michael has led global teams focused on global business development, private equity, sales operations, training and development, and business process optimization. With a commitment to outcomes and outstanding relationship management, Michael’s vision is to drive value creation for private market clients with biotech centric portfolios.

Executive Team

Levarage a Commercial Catalyst - Industry Experts Support Value Creation Opportunities

Commercial Strategy and Planning, Clinical / Corporate Development

Andy Parratt Headshot

Andy Parratt

Head, Commercial Strategy & Execution

Andy has deep commercialization expertise across a wide range of therapeutic areas and organizations ensuring that scientific innovations reach and benefit patients. He brings an integrated approach for early commercial planning encompassing R&D, market access, pricing, MR and analytics to drive the development and commercialization of assets in areas of high unmet need across US, European and global markets. Solution oriented, Andy combines operational agility with strategic focus to address meaningful challenges in healthcare.

Natalie Rettinger Headshot

Natalie Rettinger

Commercial Strategy & Planning

Natalie has over 15 years of commercialization experience, primarily in hematology/oncology with a proven track record of managing key in-line and pipeline products. A commercial thought leader with an entrepreneurial spirit, Natalie has led lifecycle management, commercial assessments and launch planning for oncology programs for mid-size global biotech and life science companies. She is also an independent product strategist in Health IT working to improve/innovate the care and communication for cancer patients.

Paresh Soni Headshot

Paresh Soni, MD, PhD

Clinical & Corporate Development

Paresh is a board-certified internist and gastroenterologist with hepatology expertise and broad medical/scientific and corporate management experience having led  clinical development programs, and global multidisciplinary teams across the development spectrum, with a proven record of multiple successful NDAs.

Operations, Finance and Business Development

Kate Worthington Headshot

Kate Worthington, PhD, MBA

Chief Operating Officer

Kate is a multidisciplinary executive with expertise in medical affairs, M&A and commercialization whose skills converge at the intersection of drug development, physician research, and data sharing. Internationally recognized for her expertise in oncology, Kate is focused on getting better medicines to patients faster and cheaper by promoting bi-directional scientific exchange and compressing time to market.

Sean McEldruff Headshot

Sean McElduff

Chief Financial Officer

Sean is an experienced finance and operational professional with exceptional expertise in accounting, pre-IPO preparedness, diligence for M&A opportunities, venture equity, FP&A, GAAP financials, and board reporting. He serves as an interim and fractional chief financial officer and finance subject matter expert providing finance operational support and guidance for start-up and clinical stage clients to ensure launch readiness and scalable growth.

Dan Silva Headshot

Daniel Silver, Esq.

Chief of Staff

Dan, an attorney by training, brings his legal expertise and experience as a biotech  coordinator to support daily operations of the leadership and executive teams, executive corporate administrative functions, vendor and partner relations and strategic implementation.

Global Patient and Market Access, Pricing and Reimbursement

Kevin Mayo Headshot

Kevin W. Mayo, PhD, EJD

SVP, Global Market Access & Health Economics

Kevin's extensive expertise in market access, pricing and reimbursement, HEOR, health policy and government affairs, and patient/medical advocacy enables him to maximize global revenue potential and market share growth. he leads patient and market access strategy and implementation.


Joseph Rubino

Reimbursement & Market Access Strategy

Joseph is a veteran market access, reimbursement and government affairs expert with interests in diagnostic and medical device strategy, HEOR and payer/provider market research. He leads projects focused on coding, coverage, payment, evidence generation, launch plans and value communication strategies.

Jennifer King headshot

Jennifer King, MBA

VP, Global Pricing & Payer Insights

Jennifer brings a wealth of commercial and market access experience across oncology and orphan drugs. She is well-versed in global, EMEA and Asia Pacific/Japan markets supporting pricing and market access strategies in both strategic development and implementation with the goal of achieving optimal access for all stakeholders.

Art Vrecenak Headshot

Art Vrecenak, PhD, MBA

Managed Markets Access

Principal at Access Acumen, Art has broad experience across field sales, health economics, product management, clinical development, hospital/GPO marketing, national HMO marketing, national PBM marketing, strategic customer marketing, and generic product business strategy. He has developed and led teams tasked with value proposition development and communication for both pharma benefit and medical benefit products. This depth and breadth of experience feeds a passion for optimizing product performance throughout the product life.

Rob Philo Headshot

Rob Philo

VP, US Practice Lead Market Access

Rob is a seasoned pharmaceutical executive with diverse and progressive experience in sales and market access. He helps clients navigate the complex and competitive U.S. payer landscape to optimize patient access and revenue potential. With a focus on the patient, Rob has successfully developed and executed national access strategies for major payers, PBMs, and government programs, resulting in significant market share and sales growth for innovative products.

Medical Affairs and Diagnostic Strategy

Radhika Tripuraneni

Radhika Tripuraneni, MD, MPH

Chief Medical Officer

Radhika brings extensive medical affairs experience that applies a business strategy to the medical need. Her expertise covering all areas of medical affairs (including scientific communications, health policy/economics) has built and expanded various market areas. A veteran of the biotech industry, her experience includes clinical development and operations, and biometrics. Radhika's formidable acumen in both medical affairs and the business of commercialization is a rare combination that drives tangible value and outcomes.

Terry Granec Headshot January 2024

Terry Granec, MSc

Chief Collaboration Officer, Medical Affairs and Commercial Strategy

Terry is a seasoned and respected biopharma veteran bringing 25 years of unique cross functional experience across Medical Affairs, Commercial, and Diagnostic Strategy specializing in rare and ultra-rare diseases. Recognized for his collaborative approach, he is adept in aligning medical affairs and commercial strategy to facilitate successful product launches. Terry has led medical affairs and field sales teams in multiple biopharma companies from large & mid cap to privately held biotech startups.

Ramin Pourfarzb Headshot

Ramin Pourfarzib, PhD

Field-Based Medical Affairs

Ray has led medical, clinical affairs and medical scientific liaison teams. He provides strategic support for national advisory boards and speaker  development programs as well as  medical and scientific training  and management of field-based scientific resources. Experienced in the implementation of clinical research studies and publications, Ray also assists with thought leader and investigator relationship management.

Tom Lo Headshot

Tom Lo, MSc

Clinical Sciences & Diagnostic Strategy

Tom has exceptional experience expanding the treatable patient population for therapeutics. With a focus on building awareness for diagnostic testing to enable optimal patient identification and timely therapy, Tom has led diagnostic strategy for eight rare diseases and provided leadership to develop and implement diagnostic strategy supporting field implementation and training across a myriad of therapeutic areas. He applies his considerable field sales acumen to ensure successful collaboration, integration, and execution of strategic diagnostic initiatives.

Commercialization of Advanced Medical Device and Life Science Support Technologies

Medical Device Commercialization

Terry Murray

Terry Murray

Chief Strategy Officer

Terry brings more than thirty—five years of progressive experience in strategic planning, business leadership, and organizational development. He has worked extensively in Europe, Asia and across the Americas in a variety of high tech, life science and medical  device environments. Terry has provided extensive guidance and execution for medical device and investor-driven start-ups seeking innovative approaches for creating market traction in emerging and established markets. Terry is the author of, “The Transformational Entrepreneur,” and a veteran of U.S. Naval Intelligence.

Barry Marston Headshot

Barry Marston

SVP, Sales Operations

Barry is a senior level medical device executive with demonstrated leadership in medical device commercialization, strategic market and human factor analysis and growth planning, sales and marketing strategy, business and product development. Focused on RCP medical device clients, Barry has led several start-up companies with successful exits. Barry also serves as mentor for medical device entrepreneurs with Rockies Venture Club and  the University of Colorado Anschutz Medical Campus.

Multidisciplinary Strategic Advisors

Edward Dow Headshot

Edward Dow, MD

Global Medical Affairs

Principal at ValueGenome, Edward is a highly experienced physician executive and practicing Hematologist-Oncologist with more than twenty-years of immuno-oncology and hematology clinical expertise combined with an extensive knowledge of global medical affairs and clinical development. Providing data generation and synthesis for medical support of new product commercialization, Ed brings global launch experience in rare blood disorders driving successful collaboration between clinical development and regulatory colleagues. Ed continues to see patients with cancer and blood diseases on a part-time basis in the community setting.

Safia Rizvi Headshot

Safia Rizvi, PhD

Early Commercial Development

CEO of CILA Therapeutics, Safia is a life science business executive and entrepreneur with more than 20 years of experience in all aspects of the biotech/pharma value chain, from discovery to commercialization. A former computational biologist with a deep understanding of AI data, informatics, clinical trials and market access, she is highly skilled at transitioning scientific concepts into product pipelines and has served as a strategic advisory for biopharma CEOs and leadership teams.

Victoria Danilchouk Headshot

Victoria Danilchouk

International Expansion, Commercialization Strategy and Digital Health

Based in Brussels, Belgium, Victoria is an industry veteran and senior advisor with expertise in commercial strategy, product management and market access. She specializes in new product strategy, commercialization, pricing, reimbursement, partnerships, with a special focus on global expansion and commercialization strategies for Europe, LATAM, MENA and APAC. Founder of Pretium Strategy, Victoria’s proficiency spans multiple therapeutic areas across both medicines and medical devices, including digital health solutions and digital therapeutics.

Katherine Rubino Headshot

Katherin Rubino, PharmD, JD

Intellectual Property Law

Partner and Chair of the Life Sciences Practice Group at Caldwell, Katie is a trained pharmacist and accomplished patent attorney who guides clients to achieve business objectives through strategic portfolio curation and monetization strategies. She works with VC-backed biotech, chemical, pharma and other life-science companies to develop global IP portfolio strategies tailored to business goals. Katie is Chair of the Chemistry and the Law division of the American Chemical Society and provides pro-bono legal advice to MIT Sandbox and MassChallenge.

Kelly DeAngelis headshot

Kelly DeAngelis

Public Relations & Communications

Founder and President at Pilcrow Group, Kelly is an award-winning communications and public relations leader with extensive experience creating and executing strategic communications plans that drive engagement and visibility. She has a proven track record of building and leading high-performing teams and is passionate about helping companies tell their stories.

Andy Verderame Headshot

Andy S. Verderame, MBA, RAC

U.S. Regulatory Affairs

As owner of FDA Regulatory, LLC, Andy is experienced in all aspects of U.S. regulatory affairs and FDA interactions. He has been an active and highly respected member of the regulatory community for decades and has personally led over 100 meetings with the FDA, managed multi-site global regulatory teams for both large and small pharma, and led preparations and presentations to FDA Advisory Committees with successful outcomes. Of note, Andy was the first industry representative invited to speak at the FDA Project Manager Forum.

Stephen Amato Headshot

Stephen F. Amato, PhD, MBA

Global Regulatory Affairs

Steve is a global regulatory affairs expert with vast experience in the healthcare sector. With a strategically oriented, collaborative and evidence-based approach, he has worked directly with the FDA and developed strategies for medical device and biopharmaceutical products. Steve is principal advisor and chief strategist at tJûn17 Life Science Advisors and serves as Department Chair and Professor of Regulatory Affairs and Quality Assurance at Northeastern University College of Professional  Studies.

Greg Fuest Headshot

Greg Fuest

Global Commercialization Strategy

Greg is an exceptional marketing and commercial strategy executive with extensive experience in large pharma and startup biotech companies leading cross-functional teams for pre-launch,  launch, re-launch and in-market brands in primary care, oncology, virology, respiratory, ERT, gene therapy and rare disease, globally and in the U.S., in addition to notable divisional/regional sales management expertise.